Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.22.2
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 60 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2016
Dec. 31, 2021
Product Liability Contingency [Line Items]            
Royalty received     $ 30,000   $ 1,332  
LIBOR interest rate $ 1,424   $ 1,424     $ 1,419
Royalties on revenues, percentage     4.00%      
Net sales percentage     3.00%      
Licensing percentage     5.00%      
Contingent Royalty Obligation 1,823   $ 1,823     $ 1,760 [1]
Gain loss on change in fair value of contingent royalty obligation $ 92 $ 37 63 $ 117    
Manufacturing Costs     285      
Severance Costs     1,428      
Royalty [Member]            
Product Liability Contingency [Line Items]            
Royalties income     20,000      
Proceeds from licensing based royalty amounts     $ 3,500      
Series A Preferred Stock [Member]            
Product Liability Contingency [Line Items]            
Percentage of payment amount     10.00%      
Private Placement [Member]            
Product Liability Contingency [Line Items]            
Net sales percentage     3.00%      
Licensing percentage     5.00%      
Royalty Payment Rights Certificates [Member]            
Product Liability Contingency [Line Items]            
Description of royalty payment     the Royalty Payment Rights initially entitled the holders in aggregate, to a royalty in an amount of      
Israeli National Authority for Technical Innovation [Member]            
Product Liability Contingency [Line Items]            
Royalty received     $ 0 $ 0    
[1] Derived from audited consolidated financial statements